Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-101126; File No. SR-NYSE-2024-18]

                    On March 27, 2024, the New York Stock Exchange LLC (“Exchange” or “NYSE”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Exchange Act”) [1]                                          and Rule 19b-4                           ( print page 78950)                        thereunder,[2]                                          a proposed rule change to amend Section 102.06 of the NYSE Listed Company Manual to provide that a special purpose acquisition company can remain listed until forty-two months from its original listing date if it has entered into a definitive agreement with respect to a business combination within three years of listing. The proposed rule change was published for comment in the                     **Federal Register**                     on April 10, 2024.[3] 

                    On May 22, 2024, pursuant to Section 19(b)(2) of the Exchange Act,[4]                                          the Commission designated a longer period within which to approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether to disapprove the proposed rule change.[5]                                          On July 9, 2024, the Commission instituted proceedings under Section 19(b)(2)(B) of the Exchange Act [6]                                          to determine whether to approve or disapprove the proposed rule change.[7] 

On September 10, 2024, the Exchange withdrew the proposed rule change (SR-NYSE-2024-18).

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[8] 

Vanessa A. Countryman,

Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 99906 (Apr. 4, 2024), 89 FR 25291 (“Notice”).                    
        Back to Citation      

4.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

5.                                                     *See*                         Securities Exchange Act Release No. 100220 (May 22, 2024), 89 FR 46527 (May 29, 2024).                    
        Back to Citation      

6.                             15 U.S.C. 78s(b)(2)(B).                    
        Back to Citation      

7.                                                     *See*                         Securities Exchange Act Release No. 100480 (July 9, 2024), 89 FR 57436 (July 15, 2024) (“OIP”). Comments received in response to the OIP can be found on the Commission's website at:                         *https://www.sec.gov/​comments/​sr-nyse-2024-18/​srnyse202418.htm.*
        Back to Citation      

8.                                 17 CFR 200.30-3(a)(12).                        
        Back to Citation      

[FR Doc. 2024-22022 Filed 9-25-24; 8:45 am]

BILLING CODE 8011-01-P